Edward Havranek
Concepts (466)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 51 | 2018 | 2326 | 2.140 |
Why?
| | Hypertension | 20 | 2022 | 1276 | 2.060 |
Why?
| | Antihypertensive Agents | 9 | 2021 | 521 | 1.680 |
Why?
| | Medication Adherence | 9 | 2022 | 540 | 1.570 |
Why?
| | Text Messaging | 5 | 2020 | 182 | 1.530 |
Why?
| | Healthcare Disparities | 8 | 2023 | 736 | 1.270 |
Why?
| | Socioeconomic Factors | 11 | 2021 | 1327 | 1.090 |
Why?
| | Heart Diseases | 3 | 2019 | 341 | 1.080 |
Why?
| | Social Values | 2 | 2021 | 40 | 1.060 |
Why?
| | Racism | 3 | 2021 | 147 | 0.980 |
Why?
| | Out-of-Hospital Cardiac Arrest | 4 | 2024 | 121 | 0.960 |
Why?
| | Health Status | 12 | 2018 | 835 | 0.940 |
Why?
| | Blood Pressure | 9 | 2016 | 1782 | 0.850 |
Why?
| | Myocardial Infarction | 17 | 2015 | 1211 | 0.850 |
Why?
| | Weight Loss | 5 | 2018 | 859 | 0.790 |
Why?
| | Cardiovascular Diseases | 11 | 2019 | 2191 | 0.790 |
Why?
| | Prediabetic State | 2 | 2016 | 250 | 0.760 |
Why?
| | Social Determinants of Health | 2 | 2018 | 309 | 0.740 |
Why?
| | Hospitalization | 24 | 2020 | 2461 | 0.740 |
Why?
| | Patient Satisfaction | 6 | 2019 | 712 | 0.730 |
Why?
| | Attitude to Health | 2 | 2021 | 430 | 0.730 |
Why?
| | Resuscitation Orders | 2 | 2020 | 48 | 0.710 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2008 | 124 | 0.700 |
Why?
| | Sexual Health | 2 | 2020 | 68 | 0.680 |
Why?
| | Physician-Patient Relations | 5 | 2013 | 588 | 0.650 |
Why?
| | Humans | 144 | 2025 | 145783 | 0.640 |
Why?
| | Sexually Transmitted Diseases | 2 | 2020 | 168 | 0.640 |
Why?
| | Health Services Accessibility | 2 | 2019 | 1101 | 0.630 |
Why?
| | Aged | 79 | 2021 | 26217 | 0.630 |
Why?
| | Health Status Disparities | 3 | 2021 | 321 | 0.600 |
Why?
| | Cardiac Output, Low | 5 | 2006 | 53 | 0.590 |
Why?
| | Middle Aged | 60 | 2022 | 36309 | 0.580 |
Why?
| | Male | 101 | 2025 | 73010 | 0.580 |
Why?
| | Female | 104 | 2025 | 79045 | 0.570 |
Why?
| | Depression | 8 | 2018 | 1559 | 0.570 |
Why?
| | Residence Characteristics | 3 | 2021 | 375 | 0.570 |
Why?
| | Primary Health Care | 4 | 2019 | 1737 | 0.560 |
Why?
| | Atherosclerosis | 2 | 2019 | 409 | 0.550 |
Why?
| | Choice Behavior | 1 | 2019 | 180 | 0.530 |
Why?
| | Diabetes Mellitus | 9 | 2018 | 1101 | 0.530 |
Why?
| | Colorado | 22 | 2021 | 4556 | 0.520 |
Why?
| | Minority Groups | 3 | 2023 | 285 | 0.500 |
Why?
| | United States | 44 | 2023 | 16126 | 0.490 |
Why?
| | Heart Arrest | 2 | 2020 | 411 | 0.470 |
Why?
| | Decision Making | 3 | 2025 | 982 | 0.460 |
Why?
| | Communication | 4 | 2023 | 977 | 0.450 |
Why?
| | American Heart Association | 3 | 2018 | 358 | 0.450 |
Why?
| | Safety-net Providers | 2 | 2018 | 130 | 0.440 |
Why?
| | Health Services Research | 2 | 2015 | 391 | 0.430 |
Why?
| | Cardiopulmonary Resuscitation | 4 | 2024 | 339 | 0.410 |
Why?
| | Quality of Health Care | 8 | 2007 | 693 | 0.410 |
Why?
| | Delivery of Health Care | 7 | 2023 | 948 | 0.400 |
Why?
| | Emergency Service, Hospital | 5 | 2021 | 2383 | 0.400 |
Why?
| | Emergency Medical Services | 4 | 2023 | 684 | 0.400 |
Why?
| | Blood Pressure Determination | 1 | 2014 | 145 | 0.380 |
Why?
| | Ventricular Dysfunction, Left | 7 | 2008 | 394 | 0.370 |
Why?
| | Risk Factors | 26 | 2019 | 10919 | 0.370 |
Why?
| | Medically Uninsured | 1 | 2013 | 132 | 0.360 |
Why?
| | Aged, 80 and over | 29 | 2021 | 8347 | 0.350 |
Why?
| | Guideline Adherence | 6 | 2021 | 587 | 0.350 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 883 | 0.350 |
Why?
| | Patient-Centered Care | 2 | 2016 | 547 | 0.340 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 2 | 2011 | 69 | 0.340 |
Why?
| | Physicians, Primary Care | 2 | 2018 | 208 | 0.340 |
Why?
| | Surveys and Questionnaires | 11 | 2024 | 6085 | 0.340 |
Why?
| | Adult | 32 | 2025 | 40881 | 0.330 |
Why?
| | Kidney Diseases | 3 | 2011 | 426 | 0.330 |
Why?
| | Carotid Artery Diseases | 1 | 2011 | 70 | 0.330 |
Why?
| | Survival Analysis | 7 | 2010 | 1378 | 0.320 |
Why?
| | Decision Support Techniques | 1 | 2015 | 480 | 0.320 |
Why?
| | Electrocardiography | 4 | 2009 | 668 | 0.320 |
Why?
| | Cohort Studies | 26 | 2020 | 6033 | 0.310 |
Why?
| | Follow-Up Studies | 17 | 2022 | 5428 | 0.310 |
Why?
| | Insurance, Health | 1 | 2013 | 311 | 0.310 |
Why?
| | Risk Assessment | 10 | 2019 | 3752 | 0.310 |
Why?
| | Coronary Artery Disease | 3 | 2013 | 750 | 0.310 |
Why?
| | Practice Patterns, Physicians' | 3 | 2018 | 1372 | 0.300 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 9 | 2008 | 229 | 0.290 |
Why?
| | Clinical Decision-Making | 2 | 2025 | 364 | 0.270 |
Why?
| | Survival Rate | 13 | 2020 | 2094 | 0.270 |
Why?
| | Attitude to Death | 1 | 2008 | 76 | 0.270 |
Why?
| | Renin-Angiotensin System | 1 | 2008 | 80 | 0.260 |
Why?
| | Heart Rate | 2 | 2011 | 856 | 0.260 |
Why?
| | Proportional Hazards Models | 11 | 2015 | 1330 | 0.260 |
Why?
| | Quality of Life | 12 | 2019 | 3211 | 0.250 |
Why?
| | Patient Education as Topic | 4 | 2018 | 777 | 0.250 |
Why?
| | Exercise | 2 | 2018 | 2205 | 0.250 |
Why?
| | Medicare | 14 | 2017 | 904 | 0.240 |
Why?
| | Diabetic Angiopathies | 4 | 2009 | 267 | 0.240 |
Why?
| | Internal Medicine | 2 | 2025 | 279 | 0.240 |
Why?
| | Stroke | 3 | 2021 | 1271 | 0.230 |
Why?
| | Sex Factors | 10 | 2020 | 2110 | 0.230 |
Why?
| | Models, Statistical | 2 | 2013 | 672 | 0.230 |
Why?
| | Kidney | 3 | 2011 | 1497 | 0.220 |
Why?
| | Atrial Fibrillation | 2 | 2009 | 558 | 0.220 |
Why?
| | Retrospective Studies | 30 | 2020 | 17330 | 0.220 |
Why?
| | Value of Life | 1 | 2005 | 19 | 0.220 |
Why?
| | Multivariate Analysis | 10 | 2017 | 1547 | 0.220 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2017 | 98 | 0.210 |
Why?
| | Prevalence | 7 | 2018 | 2875 | 0.210 |
Why?
| | Monitoring, Ambulatory | 1 | 2005 | 89 | 0.210 |
Why?
| | Ambulances | 2 | 2023 | 52 | 0.210 |
Why?
| | Cross-Sectional Studies | 14 | 2017 | 5925 | 0.210 |
Why?
| | Touch Perception | 1 | 2024 | 17 | 0.200 |
Why?
| | Patient Compliance | 4 | 2018 | 588 | 0.200 |
Why?
| | Peer Review, Research | 1 | 2004 | 36 | 0.200 |
Why?
| | Task Performance and Analysis | 1 | 2025 | 198 | 0.200 |
Why?
| | Epidemiologic Studies | 1 | 2004 | 68 | 0.200 |
Why?
| | Nisoldipine | 1 | 2003 | 7 | 0.200 |
Why?
| | Enalapril | 1 | 2003 | 16 | 0.200 |
Why?
| | Prognosis | 9 | 2018 | 4330 | 0.200 |
Why?
| | Single-Blind Method | 2 | 2021 | 318 | 0.200 |
Why?
| | Smoking Cessation | 1 | 2007 | 441 | 0.190 |
Why?
| | Shock, Traumatic | 1 | 2023 | 14 | 0.190 |
Why?
| | Young Adult | 9 | 2021 | 14254 | 0.190 |
Why?
| | Pneumonia | 2 | 2019 | 636 | 0.180 |
Why?
| | Social Class | 2 | 2019 | 264 | 0.180 |
Why?
| | Sexual Behavior | 3 | 2020 | 495 | 0.180 |
Why?
| | Attitude of Health Personnel | 2 | 2012 | 1197 | 0.180 |
Why?
| | Sepsis | 2 | 2019 | 664 | 0.180 |
Why?
| | Treatment Outcome | 15 | 2023 | 11794 | 0.180 |
Why?
| | Palliative Care | 4 | 2016 | 1022 | 0.180 |
Why?
| | Mexican Americans | 2 | 2015 | 119 | 0.180 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 79 | 0.170 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2005 | 303 | 0.170 |
Why?
| | Perception | 1 | 2004 | 378 | 0.170 |
Why?
| | Prospective Studies | 12 | 2019 | 8078 | 0.170 |
Why?
| | Acculturation | 2 | 2012 | 55 | 0.170 |
Why?
| | Communication Barriers | 1 | 2023 | 130 | 0.170 |
Why?
| | Critical Illness | 2 | 2023 | 900 | 0.170 |
Why?
| | Hypoglycemic Agents | 5 | 2012 | 1399 | 0.170 |
Why?
| | Cardiologists | 2 | 2018 | 45 | 0.160 |
Why?
| | Glomerular Filtration Rate | 5 | 2011 | 765 | 0.160 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2017 | 2602 | 0.160 |
Why?
| | Stroke Volume | 7 | 2008 | 655 | 0.160 |
Why?
| | Drug Prescriptions | 6 | 2009 | 288 | 0.160 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 147 | 0.160 |
Why?
| | Brain Ischemia | 2 | 2021 | 359 | 0.160 |
Why?
| | Writing | 1 | 2021 | 101 | 0.160 |
Why?
| | Telemedicine | 2 | 2011 | 967 | 0.160 |
Why?
| | Interviews as Topic | 4 | 2025 | 916 | 0.160 |
Why?
| | Electronic Health Records | 2 | 2018 | 1202 | 0.150 |
Why?
| | Age Factors | 11 | 2018 | 3346 | 0.150 |
Why?
| | Chi-Square Distribution | 5 | 2015 | 528 | 0.150 |
Why?
| | Incidence | 6 | 2021 | 2934 | 0.150 |
Why?
| | Chronic Disease | 6 | 2018 | 1812 | 0.150 |
Why?
| | Quality Assurance, Health Care | 6 | 2007 | 342 | 0.150 |
Why?
| | Health Care Surveys | 4 | 2019 | 536 | 0.150 |
Why?
| | Adolescent | 10 | 2020 | 22577 | 0.150 |
Why?
| | Intensive Care Units | 1 | 2025 | 924 | 0.140 |
Why?
| | Public Opinion | 1 | 2019 | 62 | 0.140 |
Why?
| | Shock | 1 | 2020 | 110 | 0.140 |
Why?
| | Fluid Therapy | 1 | 2020 | 155 | 0.140 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2024 | 1420 | 0.140 |
Why?
| | Income | 1 | 2019 | 203 | 0.140 |
Why?
| | Cardiology | 3 | 2007 | 362 | 0.140 |
Why?
| | Time Factors | 10 | 2015 | 7134 | 0.140 |
Why?
| | Emergency Treatment | 1 | 2019 | 123 | 0.140 |
Why?
| | Medical Audit | 1 | 2018 | 77 | 0.140 |
Why?
| | Formative Feedback | 1 | 2018 | 36 | 0.140 |
Why?
| | Cognition | 2 | 2025 | 1271 | 0.130 |
Why?
| | Withholding Treatment | 2 | 2016 | 80 | 0.130 |
Why?
| | Patient Selection | 5 | 2009 | 739 | 0.130 |
Why?
| | Multilevel Analysis | 1 | 2017 | 36 | 0.130 |
Why?
| | Health Literacy | 2 | 2018 | 186 | 0.130 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2933 | 0.130 |
Why?
| | Censuses | 1 | 2017 | 33 | 0.130 |
Why?
| | Angina Pectoris | 2 | 2008 | 76 | 0.130 |
Why?
| | Patient Readmission | 5 | 2012 | 773 | 0.130 |
Why?
| | Odds Ratio | 6 | 2018 | 1083 | 0.130 |
Why?
| | California | 1 | 2019 | 473 | 0.130 |
Why?
| | Contraception | 1 | 2019 | 170 | 0.130 |
Why?
| | International Cooperation | 1 | 2018 | 197 | 0.130 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2017 | 64 | 0.130 |
Why?
| | Patient Care Team | 2 | 2018 | 697 | 0.130 |
Why?
| | Statistics as Topic | 3 | 2008 | 283 | 0.130 |
Why?
| | Goals | 1 | 2018 | 185 | 0.120 |
Why?
| | Comorbidity | 9 | 2012 | 1662 | 0.120 |
Why?
| | Hyperglycemia | 3 | 2010 | 380 | 0.120 |
Why?
| | Patient Navigation | 1 | 2019 | 126 | 0.120 |
Why?
| | Peer Group | 1 | 2019 | 256 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 368 | 0.120 |
Why?
| | Logistic Models | 9 | 2017 | 2139 | 0.120 |
Why?
| | Physicians | 1 | 2025 | 956 | 0.120 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2016 | 75 | 0.120 |
Why?
| | Diuretics | 3 | 2006 | 68 | 0.120 |
Why?
| | Organizational Case Studies | 1 | 2015 | 69 | 0.120 |
Why?
| | Cell Phone | 1 | 2016 | 82 | 0.110 |
Why?
| | Qualitative Research | 3 | 2019 | 1683 | 0.110 |
Why?
| | Hospital Mortality | 5 | 2019 | 1038 | 0.110 |
Why?
| | Urban Population | 1 | 2018 | 494 | 0.110 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 140 | 0.110 |
Why?
| | Internship and Residency | 2 | 2025 | 1269 | 0.110 |
Why?
| | Xanthines | 2 | 2007 | 23 | 0.110 |
Why?
| | Diffusion of Innovation | 1 | 2015 | 96 | 0.110 |
Why?
| | Organizational Innovation | 1 | 2015 | 119 | 0.110 |
Why?
| | Self-Management | 1 | 2018 | 204 | 0.110 |
Why?
| | Thiazolidinediones | 3 | 2005 | 143 | 0.110 |
Why?
| | Leadership | 2 | 2018 | 402 | 0.110 |
Why?
| | Predictive Value of Tests | 4 | 2010 | 2123 | 0.110 |
Why?
| | Hypercholesterolemia | 1 | 2015 | 95 | 0.110 |
Why?
| | Community Health Services | 2 | 2008 | 231 | 0.110 |
Why?
| | Renal Dialysis | 1 | 2019 | 466 | 0.110 |
Why?
| | Blood Vessels | 1 | 2016 | 167 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 630 | 0.110 |
Why?
| | Education, Medical | 1 | 2018 | 276 | 0.110 |
Why?
| | Cultural Competency | 2 | 2013 | 89 | 0.110 |
Why?
| | Registries | 6 | 2020 | 2410 | 0.100 |
Why?
| | Lipoproteins | 1 | 2015 | 166 | 0.100 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 143 | 0.100 |
Why?
| | Organizational Culture | 1 | 2015 | 162 | 0.100 |
Why?
| | Acute Coronary Syndrome | 1 | 2017 | 297 | 0.100 |
Why?
| | Adiponectin | 1 | 2015 | 242 | 0.100 |
Why?
| | Ventricular Function, Left | 4 | 2009 | 544 | 0.100 |
Why?
| | ROC Curve | 2 | 2020 | 618 | 0.100 |
Why?
| | Practice Guidelines as Topic | 4 | 2017 | 1582 | 0.100 |
Why?
| | Cholesterol | 1 | 2015 | 408 | 0.100 |
Why?
| | Creatinine | 5 | 2006 | 515 | 0.100 |
Why?
| | Triglycerides | 1 | 2015 | 520 | 0.100 |
Why?
| | Aspirin | 3 | 2005 | 406 | 0.090 |
Why?
| | Disease Management | 3 | 2008 | 653 | 0.090 |
Why?
| | Pilot Projects | 3 | 2015 | 1898 | 0.090 |
Why?
| | Kidney Failure, Chronic | 1 | 2019 | 599 | 0.090 |
Why?
| | Diabetes Complications | 3 | 2009 | 225 | 0.090 |
Why?
| | Metformin | 3 | 2005 | 329 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 2 | 2015 | 971 | 0.090 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 444 | 0.090 |
Why?
| | Inpatients | 5 | 2009 | 553 | 0.090 |
Why?
| | Hyperlipidemias | 1 | 2012 | 120 | 0.090 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 252 | 0.080 |
Why?
| | Hospitals, Military | 1 | 2011 | 29 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2005 | 1752 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 2000 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 532 | 0.080 |
Why?
| | Medical Laboratory Science | 1 | 2010 | 9 | 0.080 |
Why?
| | Trust | 1 | 2012 | 158 | 0.080 |
Why?
| | Vascular Stiffness | 1 | 2015 | 487 | 0.080 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 155 | 0.080 |
Why?
| | Health Promotion | 1 | 2017 | 775 | 0.080 |
Why?
| | Biomedical Research | 2 | 2007 | 719 | 0.080 |
Why?
| | Diet | 2 | 2015 | 1278 | 0.080 |
Why?
| | Telephone | 1 | 2011 | 177 | 0.080 |
Why?
| | Health Status Indicators | 3 | 2008 | 167 | 0.080 |
Why?
| | Affect | 1 | 2012 | 321 | 0.080 |
Why?
| | Pregnancy | 2 | 2020 | 7216 | 0.080 |
Why?
| | Double-Blind Method | 4 | 2015 | 2064 | 0.070 |
Why?
| | Nutrition Surveys | 2 | 2008 | 279 | 0.070 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2009 | 156 | 0.070 |
Why?
| | Body Mass Index | 2 | 2016 | 2447 | 0.070 |
Why?
| | Captopril | 1 | 2008 | 11 | 0.070 |
Why?
| | Valsartan | 1 | 2008 | 32 | 0.070 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 38 | 0.070 |
Why?
| | Propanolamines | 1 | 2008 | 40 | 0.070 |
Why?
| | Spouse Abuse | 1 | 2008 | 39 | 0.070 |
Why?
| | Tetrazoles | 1 | 2008 | 50 | 0.070 |
Why?
| | Carbazoles | 1 | 2008 | 53 | 0.070 |
Why?
| | Obesity | 2 | 2015 | 3118 | 0.070 |
Why?
| | Pharmacists | 1 | 2011 | 258 | 0.070 |
Why?
| | Spironolactone | 2 | 2005 | 40 | 0.070 |
Why?
| | Valine | 1 | 2008 | 83 | 0.070 |
Why?
| | Spirituality | 1 | 2009 | 88 | 0.070 |
Why?
| | Linear Models | 4 | 2015 | 849 | 0.070 |
Why?
| | Health Surveys | 1 | 2010 | 520 | 0.070 |
Why?
| | Adenosine A1 Receptor Antagonists | 1 | 2007 | 2 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 95 | 0.070 |
Why?
| | Patients | 1 | 2009 | 183 | 0.060 |
Why?
| | Medically Underserved Area | 1 | 2008 | 100 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2011 | 2968 | 0.060 |
Why?
| | Insulin Resistance | 1 | 2015 | 1244 | 0.060 |
Why?
| | Social Workers | 2 | 2018 | 55 | 0.060 |
Why?
| | Vascular Diseases | 1 | 2009 | 252 | 0.060 |
Why?
| | Self Care | 1 | 2009 | 392 | 0.060 |
Why?
| | Blood Urea Nitrogen | 1 | 2006 | 53 | 0.060 |
Why?
| | United States Department of Veterans Affairs | 1 | 2011 | 779 | 0.060 |
Why?
| | Asthma | 1 | 2018 | 1797 | 0.060 |
Why?
| | Defibrillators, Implantable | 1 | 2010 | 387 | 0.060 |
Why?
| | Diet, Sodium-Restricted | 1 | 2006 | 38 | 0.060 |
Why?
| | National Health Programs | 1 | 2005 | 23 | 0.060 |
Why?
| | Drug Monitoring | 1 | 2009 | 401 | 0.060 |
Why?
| | Heuristics | 1 | 2025 | 11 | 0.060 |
Why?
| | Dyspnea | 2 | 2018 | 250 | 0.060 |
Why?
| | Patient Admission | 4 | 2009 | 220 | 0.060 |
Why?
| | Edema | 1 | 2006 | 125 | 0.060 |
Why?
| | Coronary Artery Bypass | 2 | 2006 | 268 | 0.060 |
Why?
| | Body Temperature | 1 | 2006 | 227 | 0.060 |
Why?
| | Biomarkers | 6 | 2015 | 4302 | 0.050 |
Why?
| | Interinstitutional Relations | 1 | 2005 | 56 | 0.050 |
Why?
| | Health Education | 1 | 2008 | 346 | 0.050 |
Why?
| | Cost of Illness | 2 | 2004 | 324 | 0.050 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2005 | 109 | 0.050 |
Why?
| | Nurses | 2 | 2018 | 171 | 0.050 |
Why?
| | Fatigue | 2 | 2018 | 366 | 0.050 |
Why?
| | Terminally Ill | 1 | 2005 | 40 | 0.050 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2005 | 84 | 0.050 |
Why?
| | Hospital Costs | 1 | 2005 | 125 | 0.050 |
Why?
| | Self Report | 2 | 2022 | 876 | 0.050 |
Why?
| | Patient Discharge | 4 | 2006 | 995 | 0.050 |
Why?
| | Specialization | 1 | 2005 | 137 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2007 | 374 | 0.050 |
Why?
| | Drug Costs | 1 | 2005 | 117 | 0.050 |
Why?
| | Coronary Care Units | 1 | 2004 | 27 | 0.050 |
Why?
| | Counseling | 1 | 2007 | 401 | 0.050 |
Why?
| | Anemia | 1 | 2005 | 191 | 0.050 |
Why?
| | United Kingdom | 1 | 2005 | 358 | 0.050 |
Why?
| | Nurse Administrators | 1 | 2004 | 42 | 0.050 |
Why?
| | Cultural Characteristics | 1 | 2004 | 69 | 0.050 |
Why?
| | Medicine | 1 | 2005 | 125 | 0.050 |
Why?
| | Educational Status | 1 | 2006 | 470 | 0.050 |
Why?
| | Nurse Practitioners | 1 | 2006 | 141 | 0.050 |
Why?
| | North America | 1 | 2004 | 304 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2005 | 413 | 0.050 |
Why?
| | Ibuprofen | 1 | 2003 | 87 | 0.050 |
Why?
| | Internet | 1 | 2008 | 693 | 0.050 |
Why?
| | Albuminuria | 1 | 2004 | 189 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2004 | 176 | 0.050 |
Why?
| | Patient Reported Outcome Measures | 2 | 2018 | 498 | 0.050 |
Why?
| | Alcohol Drinking | 2 | 2009 | 843 | 0.050 |
Why?
| | Thiazoles | 1 | 2003 | 142 | 0.050 |
Why?
| | Health Behavior | 2 | 2011 | 791 | 0.050 |
Why?
| | Risk Reduction Behavior | 1 | 2004 | 217 | 0.050 |
Why?
| | Purinergic P1 Receptor Antagonists | 1 | 2002 | 10 | 0.050 |
Why?
| | Diuresis | 1 | 2002 | 10 | 0.050 |
Why?
| | Hypertension, Malignant | 1 | 2002 | 3 | 0.050 |
Why?
| | Continuity of Patient Care | 1 | 2005 | 297 | 0.050 |
Why?
| | Calcium Channel Blockers | 1 | 2003 | 166 | 0.040 |
Why?
| | Cardiac Tamponade | 1 | 2002 | 15 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2004 | 421 | 0.040 |
Why?
| | South Africa | 1 | 2023 | 266 | 0.040 |
Why?
| | Needs Assessment | 1 | 2005 | 403 | 0.040 |
Why?
| | Furosemide | 1 | 2002 | 37 | 0.040 |
Why?
| | Weight Gain | 1 | 2006 | 561 | 0.040 |
Why?
| | Total Quality Management | 1 | 2002 | 57 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2005 | 463 | 0.040 |
Why?
| | Pain Measurement | 1 | 2004 | 562 | 0.040 |
Why?
| | Lupus Nephritis | 1 | 2002 | 67 | 0.040 |
Why?
| | Hospice Care | 1 | 2005 | 228 | 0.040 |
Why?
| | Health Care Costs | 1 | 2004 | 425 | 0.040 |
Why?
| | Ambulatory Care | 2 | 2006 | 610 | 0.040 |
Why?
| | Health Maintenance Organizations | 2 | 2012 | 105 | 0.040 |
Why?
| | Forecasting | 1 | 2002 | 390 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 346 | 0.040 |
Why?
| | Mortality | 2 | 2018 | 381 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1851 | 0.040 |
Why?
| | Family Practice | 1 | 2004 | 407 | 0.040 |
Why?
| | Contraindications | 3 | 2005 | 90 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2012 | 330 | 0.040 |
Why?
| | Emergencies | 1 | 2021 | 174 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2003 | 499 | 0.040 |
Why?
| | Risk Adjustment | 1 | 2020 | 85 | 0.040 |
Why?
| | Coronary Disease | 1 | 2002 | 382 | 0.040 |
Why?
| | Area Under Curve | 1 | 2020 | 332 | 0.040 |
Why?
| | Sexuality | 1 | 2019 | 32 | 0.040 |
Why?
| | Blood Glucose | 2 | 2009 | 2344 | 0.040 |
Why?
| | Research | 2 | 2018 | 431 | 0.040 |
Why?
| | Electric Countershock | 1 | 2019 | 126 | 0.040 |
Why?
| | Geographic Mapping | 1 | 2018 | 26 | 0.040 |
Why?
| | Veterans | 1 | 2011 | 1642 | 0.030 |
Why?
| | Program Evaluation | 2 | 2018 | 944 | 0.030 |
Why?
| | Hospitals | 1 | 2003 | 733 | 0.030 |
Why?
| | Length of Stay | 2 | 2017 | 1350 | 0.030 |
Why?
| | Zimbabwe | 1 | 2018 | 76 | 0.030 |
Why?
| | Palliative Medicine | 1 | 2018 | 24 | 0.030 |
Why?
| | Patient Health Questionnaire | 1 | 2018 | 40 | 0.030 |
Why?
| | Alcoholism | 1 | 2004 | 826 | 0.030 |
Why?
| | Cholesterol, LDL | 2 | 2012 | 360 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2011 | 1271 | 0.030 |
Why?
| | Capacity Building | 1 | 2018 | 62 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2020 | 1300 | 0.030 |
Why?
| | Clinical Competence | 1 | 2025 | 1247 | 0.030 |
Why?
| | Resuscitation | 1 | 2020 | 312 | 0.030 |
Why?
| | Anxiety | 2 | 2018 | 1122 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 388 | 0.030 |
Why?
| | Peer Review | 2 | 2007 | 47 | 0.030 |
Why?
| | Secondary Prevention | 1 | 2018 | 251 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 251 | 0.030 |
Why?
| | Primary Prevention | 1 | 2018 | 222 | 0.030 |
Why?
| | Sex Offenses | 1 | 2019 | 196 | 0.030 |
Why?
| | Diet Surveys | 1 | 2015 | 90 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 99 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2017 | 244 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 484 | 0.030 |
Why?
| | Motivation | 1 | 2020 | 602 | 0.030 |
Why?
| | Emergency Medicine | 1 | 2018 | 282 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 219 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2016 | 267 | 0.030 |
Why?
| | Medical Records | 2 | 2006 | 192 | 0.030 |
Why?
| | Canada | 2 | 2006 | 432 | 0.030 |
Why?
| | Consensus | 2 | 2007 | 479 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2020 | 714 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2002 | 920 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1115 | 0.030 |
Why?
| | Regression Analysis | 2 | 2009 | 1001 | 0.030 |
Why?
| | Language | 1 | 2017 | 324 | 0.020 |
Why?
| | Administration, Oral | 2 | 2007 | 867 | 0.020 |
Why?
| | Mineralocorticoid Receptor Antagonists | 2 | 2005 | 69 | 0.020 |
Why?
| | Neoplasms | 1 | 2009 | 2913 | 0.020 |
Why?
| | Stereotyped Behavior | 1 | 2012 | 21 | 0.020 |
Why?
| | Pain Management | 1 | 2016 | 411 | 0.020 |
Why?
| | Up-Regulation | 1 | 2015 | 848 | 0.020 |
Why?
| | Pain | 1 | 2018 | 791 | 0.020 |
Why?
| | Quality Indicators, Health Care | 2 | 2006 | 336 | 0.020 |
Why?
| | Aging | 1 | 2003 | 1973 | 0.020 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2012 | 63 | 0.020 |
Why?
| | Disease Progression | 2 | 2011 | 2865 | 0.020 |
Why?
| | Culture | 1 | 2012 | 124 | 0.020 |
Why?
| | Speech Recognition Software | 1 | 2010 | 9 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2007 | 2028 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2010 | 165 | 0.020 |
Why?
| | Cause of Death | 1 | 2012 | 472 | 0.020 |
Why?
| | Medication Therapy Management | 1 | 2010 | 72 | 0.020 |
Why?
| | Urban Health Services | 1 | 2009 | 69 | 0.020 |
Why?
| | Hospitals, University | 1 | 2008 | 176 | 0.020 |
Why?
| | Natriuresis | 1 | 2007 | 13 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1925 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2007 | 156 | 0.020 |
Why?
| | Ontario | 1 | 2006 | 90 | 0.020 |
Why?
| | Risk | 1 | 2009 | 923 | 0.020 |
Why?
| | Patient Participation | 1 | 2010 | 446 | 0.020 |
Why?
| | Lovastatin | 1 | 2006 | 37 | 0.010 |
Why?
| | Pravastatin | 1 | 2006 | 45 | 0.010 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2006 | 55 | 0.010 |
Why?
| | Heptanoic Acids | 1 | 2006 | 67 | 0.010 |
Why?
| | Databases as Topic | 1 | 2005 | 71 | 0.010 |
Why?
| | Hematocrit | 1 | 2005 | 108 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 782 | 0.010 |
Why?
| | Sleep Wake Disorders | 1 | 2009 | 314 | 0.010 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 121 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2009 | 544 | 0.010 |
Why?
| | Hospitals, Urban | 1 | 2005 | 142 | 0.010 |
Why?
| | Midwestern United States | 1 | 2004 | 44 | 0.010 |
Why?
| | Northwestern United States | 1 | 2004 | 58 | 0.010 |
Why?
| | Potassium | 1 | 2005 | 152 | 0.010 |
Why?
| | Pyrroles | 1 | 2006 | 220 | 0.010 |
Why?
| | Age Distribution | 1 | 2005 | 404 | 0.010 |
Why?
| | Family | 1 | 2009 | 685 | 0.010 |
Why?
| | Hospitals, Municipal | 1 | 2004 | 1 | 0.010 |
Why?
| | Myocardial Revascularization | 1 | 2004 | 85 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 2006 | 770 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1477 | 0.010 |
Why?
| | Drug Utilization | 1 | 2004 | 168 | 0.010 |
Why?
| | Drug Utilization Review | 1 | 2003 | 61 | 0.010 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2004 | 144 | 0.010 |
Why?
| | Cardiotonic Agents | 1 | 2003 | 94 | 0.010 |
Why?
| | Fee-for-Service Plans | 1 | 2003 | 99 | 0.010 |
Why?
| | Drug Interactions | 1 | 2003 | 405 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 2005 | 356 | 0.010 |
Why?
| | Electrolytes | 1 | 2002 | 54 | 0.010 |
Why?
| | Indoles | 1 | 2006 | 507 | 0.010 |
Why?
| | Urinalysis | 1 | 2002 | 83 | 0.010 |
Why?
| | Overweight | 1 | 2006 | 614 | 0.010 |
Why?
| | Pyridines | 1 | 2006 | 609 | 0.010 |
Why?
| | Sodium | 1 | 2002 | 198 | 0.010 |
Why?
| | Cardiac Catheterization | 1 | 2004 | 559 | 0.010 |
Why?
| | Morbidity | 1 | 2002 | 322 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 1043 | 0.010 |
Why?
| | Drug Combinations | 1 | 2002 | 396 | 0.010 |
Why?
| | Diabetic Nephropathies | 1 | 2004 | 322 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2005 | 756 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2002 | 610 | 0.010 |
Why?
| | Recovery of Function | 1 | 2003 | 716 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2005 | 869 | 0.010 |
Why?
| | Mental Disorders | 1 | 2008 | 1171 | 0.010 |
Why?
| | Substance-Related Disorders | 1 | 2008 | 1103 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3634 | 0.010 |
Why?
| | Hemodynamics | 1 | 2002 | 1118 | 0.010 |
Why?
|
|
Havranek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|